Proteomic Approaches to Defining Remission and the Risk of Relapse in Rheumatoid Arthritis

Proteomic Approaches to Defining Remission and the Risk of Relapse in Rheumatoid Arthritis

ObjectivesPatients with Rheumatoid Arthritis (RA) are increasingly achieving stable disease remission, yet the mechanisms that govern ongoing clinical disease and subsequent risk of future flare are not well understood. We sought to identify serum proteomic alterations that dictate clinically import...

Full description

Bibliographic Details
Main Authors: Liam J. O’Neil, Pingzhao Hu, Qian Liu, Md. Mohaiminul Islam, Victor Spicer, Juergen Rech, Axel Hueber, Vidyanand Anaparti, Irene Smolik, Hani S. El-Gabalawy, Georg Schett, John A. Wilkins
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-11-01
Series:Frontiers in Immunology
Subjects:
rheumatoid arthritis
disease activity
outcomes research
treatment
proteomics
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.729681/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.729681/full

Similar Items